BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 9 Issue 4 Pages: e94699 Pub: 2014 Epub: 2014 Apr 10 Authors Rossi G , Pengo G , Caldin M , Palumbo Piccionello A , Steiner JM , Cohen ND , Jergens AE , Suchodolski JS , |
|
|
Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 9 Issue 4 Pages: e94699 Pub: 2014 Epub: 2014 Apr 10 Authors Rossi G , Pengo G , Caldin M , Palumbo Piccionello A , Steiner JM , Cohen ND , Jergens AE , Suchodolski JS , |
|
|
VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice. ✅
Go to Publication ✅
World journal of gastroenterology (World J Gastroenterol ) Vol: 24 Issue 37 Pages: 4254-4262 Pub: 2018 Oct 7 Epub: Authors Wang CS , Li WB , Wang HY , Ma YM , Zhao XH , Yang H , Qian JM , Li JN , |
|
|
Probiotic colonization dynamics after oral consumption of VSL#3(®) by antibiotic-treated mice. ✅
Go to Publication ✅
Microbiome research reports (Microbiome Res Rep ) Vol: 1 Issue 4 Pages: 21 Pub: 2022 Epub: 2022 Jul 19 Authors Theriot C , Thanissery R , O'Flaherty S , Barrangou R , |
|
|
Probiotics VSL#3 are effective in reversing non-alcoholic steatohepatitis in a mouse model. ✅
Go to Publication ✅
Hepatobiliary surgery and nutrition (Hepatobiliary Surg Nutr ) Vol: 9 Issue 2 Pages: 170-182 Pub: 2020 Apr Epub: Authors Jena PK , Sheng L , Li Y , Wan YY , |
|
|
Probiotics VSL#3 are effective in reversing non-alcoholic steatohepatitis in a mouse model. ✅
Go to Publication ✅
Hepatobiliary surgery and nutrition (Hepatobiliary Surg Nutr ) Vol: 9 Issue 2 Pages: 170-182 Pub: 2020 Apr Epub: Authors Jena PK , Sheng L , Li Y , Wan YY , |
|
|
Probiotics VSL#3 are effective in reversing non-alcoholic steatohepatitis in a mouse model. ✅
Go to Publication ✅
Hepatobiliary surgery and nutrition (Hepatobiliary Surg Nutr ) Vol: 9 Issue 2 Pages: 170-182 Pub: 2020 Apr Epub: Authors Jena PK , Sheng L , Li Y , Wan YY , |
|
|
Probiotics VSL#3 are effective in reversing non-alcoholic steatohepatitis in a mouse model. ✅
Go to Publication ✅
Hepatobiliary surgery and nutrition (Hepatobiliary Surg Nutr ) Vol: 9 Issue 2 Pages: 170-182 Pub: 2020 Apr Epub: Authors Jena PK , Sheng L , Li Y , Wan YY , |
|
|
Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: 5 Issue 4 Pages: 494-503 Pub: 2014 Jul 1 Epub: 2014 Aug 4 Authors Mar JS , Nagalingam NA , Song Y , Onizawa M , Lee JW , Lynch SV , |
|
|
Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: 5 Issue 4 Pages: 494-503 Pub: 2014 Jul 1 Epub: 2014 Aug 4 Authors Mar JS , Nagalingam NA , Song Y , Onizawa M , Lee JW , Lynch SV , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
